跳至正文
佰默生物 项目咨询
首页/SIMOA/Assay Kits

SIMOA / ASSAY

IL-17A

Interleukin 17A (IL-17A) is disulfide-linked homodimeric cytokine of 155 amino acids (molecular weight 35kDa) and a member of an IL-17 family of related cytokines (IL-17B through IL-17F). All IL-17 cytokines have a similar protein structure, and no sequence similarity to any other cytokines.

IL-17A 原有产品资料图
原有产品资料图 · 点击放大查看
查看完整产品简介

询价 (Tel. 15750729215)

IL-17A

Interleukin 17A (IL-17A) is disulfide-linked homodimeric cytokine of 155 amino acids (molecular weight 35kDa) and a member of an IL-17 family of related cytokines (IL-17B through IL-17F). All IL-17 cytokines have a similar protein structure, and no sequence similarity to any other cytokines.

产品说明

IL-17A

Interleukin 17A (IL-17A) is disulfide-linked homodimeric cytokine of 155 amino acids (molecular weight 35kDa) and a member of an IL-17 family of related cytokines (IL-17B through IL-17F). All IL-17 cytokines have a similar protein structure, and no sequence similarity to any other cytokines. These cytokines are well conserved in mammals, with significant sequence conservation between the human and mouse homologs. A major role of IL-17A is its involvement in inducing and mediating proinflammatory responses. It acts as a potent mediator in delayed-type reactions by increasing chemokine production in various tissues to recruit monocytes and neutrophils to the site of inflammation, similar to interferon gamma. IL-17A is produced by T-helper cells and is induced by IL–23 which results in destructive tissue damage in delayed-type reactions. IL-17 induces the production of many other synergistic cytokines, including GM-CSF, IL-6, IL-1b, and TNFa. The IL-17 family has been linked to many immune/autoimmune related diseases including rheumatoid arthritis, asthma, lupus, allograft rejection, anti-tumor immunity and recently psoriasis.

REQUEST MORE INFORMATION

IL-17A in Neurodegeneration

In neurodegenerative diseases, IL-17A is thought to contribute to disease progression by promoting inflammation and neurotoxicity. For example, IL-17A levels are elevated in the brains of patients with Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). In addition, studies have shown that blocking IL-17A signaling can protect against neurodegeneration in animal models of these diseases.

Researchers are currently investigating the role of IL-17A in neurodegeneration and developing new ways to block IL-17A signaling as a potential treatment for these diseases. For example, some clinical trials are currently underway to evaluate the safety and efficacy of IL-17A inhibitors in patients with multiple sclerosis and ALS.

Applications and Intended Use

The IL-17A assay is a digital immunoassay for the quantitative determination of IL-17A in serum and plasma.

Compatible Instruments

  • Advantage Plus: HD-X/SR-X
  • Advantage: HD-1/HD-X/SR-X

Kit Contents

The assay kit includes all necessary reagents and controls to perform 96 tests, making it easy to use and compatible with various sample types.

Related Resources

资料下载

保留原有原厂资料入口。不同仪器与版本的参数,请逐一核对对应文件。

Data Sheet

Safety Data Sheets

Certificates Of Analysis

文献与引用

通过 Bioz 查看这款产品的引用文献、应用摘要与研究图片。

Bioz · 产品引用与应用文献在 Bioz 打开 ↗

Bioz 实时文献组件 · 可在组件内筛选和滚动浏览;无法载入时可在 Bioz 打开。

Powered by Bioz

您想从哪一步开始?

BIOMO / 站内搜索

你想找到什么?

从产品、科研服务到技术资料。

常用检索

单细胞VisiumDDA / DIASIMOAmIHCOlink

评估科研项目

留下研究目标和联系方式,便于进一步沟通。

不确定的项目可以留空,我们一起确认。

提交的信息将用于回复本次咨询,由佰默团队接收处理。

也可联系 panxu@biomobio.com